23 completed, 9 unknown, 6 recruiting, 6 terminated. 24 Not applicable, 6 Phase 2, 6 Phase 4, 2 Phase 1, 2 Phase 3.
Follow BPH: new trials by email Literature Review of BPH trials Research Report on BPH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction High Intensity Focused Ultrasound - Bladder Outlet Obstruction, BPH | Not applicable | Not yet recruiting | Icahn School of Medicine at Mount Sinai | 17 | 2026-11-01 | 2026-10-09 |
| HoLEP Sexual Survivorship Telephone Interview, Questionnaires over the span of 24 months - BPH, Lower Urinary Tract Symptoms | Enrolling by invitation | Northwestern University | 252 | 2026-05-26 | 2026-10-15 | |
| High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia H-FIRE, Surgical Standard of Care (TURP or HoLEP) - BPH | Not applicable | Not yet recruiting | Shanghai East Hospital | 288 | 2026-05-05 | 2026-05-07 |
| Blue Diode Laser Vaporization for BPH Blue diode laser - BPH | Not applicable | Recruiting | Chinese University of Hong Kong | 10 | 2025-06-26 | 2025-08-11 |
| INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms INTUPRO ionic fluid - BPH (Benign Prostatic Hyperplasia), BPH | Not applicable | Recruiting | inTumo Therapeutics, Inc. | 31 | 2025-03-04 | 2026-02-02 |
| Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity Bipolar enucleation of the prostate (BipolEP), Intravesical Botox injection - BPH, Intravesical Botox | Not applicable | Unknown | Menoufia University | 100 | 2025-01-01 | 2024-05-17 |
| Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH. Tamsulosin, 5-hidroxitriptophan - BPH, LUTS(Lower Urinary Tract Symptoms) | Phase 2 | Recruiting | Clinical Academic Center (2CA-Braga) | 70 | 2024-12-20 | 2025-01-06 |
| Evaluation of SureCore Plus Biopsy System Evaluation of two biopsy systems - BPH | Not applicable | Unknown | Uro-1 Medical | 30 | 2024-08-05 | 2024-08-13 |
| Effect of Group Preoperative Pelvic Floor Training for HoLEP Group preoperative pelvic floor training - BPH, Urinary Incontinence | Recruiting | University of California, San Francisco | 100 | 2024-02-07 | 2026-07-17 | |
| US Imaging for the Assessment of LUTS MRI-UDS; US-UDS; MCUD - Lower Urinary Tract Symptoms, BPH | Recruiting | University of Wisconsin, Madison | 80 | 2023-11-28 | 2025-12-22 | |
| Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate Ejaculatory Preserving Transurethral resection of prostate, Standard Transurethral Resection of prostate - Ejaculatory Dysfunction, BPH | Not applicable | Completed | Sohag University | 90 | 2023-07-01 | 2026-01-06 |
| Data Collection Post Radical Prostatectomy Control - Stress Urinary Incontinence, Radical Prostatectomy | Completed | Levee Medical, Inc. | 30 | 2023-03-30 | 2025-09-29 | |
| Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP Furosemide - BPH With Urinary Obstruction, BPH | Phase 3 | Recruiting | Northwestern University | 138 | 2023-03-01 | 2023-09-13 |
| Transurethral Resection Versus Transurethral Enucleation of the Prostate: Prospective Randomized Study Transurethral resection of the prostate, transurethral enucleation of prostate - BPH | Not applicable | Unknown | Assiut University | 58 | 2022-04-30 | 2022-04-15 |
| Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH UroLift System, Tamsulosin Hydrochloride - BPH | Phase 4 | Unknown | NeoTract, Inc. | 250 | 2021-12-06 | 2023-04-25 |
| Simulation-Based Enucleation Training: Initial Experience Using 3D-printed Organ Phantoms Organ phantom of prostate - BPH | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 15 | 2021-11-23 | 2022-11-28 | |
| SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia SOLTIVE Thulium Laser, Standard of Care (Holmium Laser) - BPH, Benign Prostatic Hyperplasia | Completed | University of Kansas Medical Center | 15 | 2021-04-14 | 2024-10-02 | |
| Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL) Butterfly Medical Prostatic Retraction Device ("the Butterfly device") removal/replacement - BPH, BOO - Bladder Outflow Obstruction | Not applicable | Active not recruiting | Butterfly Medical Ltd. | 60 | 2021-02-10 | 2026-06-01 |
| Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study Tamsulosin, Tadalafil - BPH | Phase 4 | Completed | Mansoura University | 160 | 2020-11-11 | 2023-04-19 |
| Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia Prostatic Artery Embolization (HydroPearl® compressible microspheres) - BPH, Enlarged Prostate (BPH) | Not applicable | Terminated | University of North Carolina, Chapel Hill | 12 | 2020-09-23 | 2024-05-07 |
Showing 20 of 49. Sign in to see all of them.
Prostatic Hyperplasia (13) · Lower Urinary Tract Symptoms (9) · Urinary Bladder Neck Obstruction (4) · Erectile Dysfunction (2) · Nocturia (2) · Prostatitis (2) · Retrograde Ejaculation (2) · Urinary Bladder, Overactive (2) · Bronchiolitis Obliterans Syndrome (1) · Depression (1) · Diabetes Mellitus (1) · Ejaculatory Dysfunction (1) · Heart Failure (1) · Hematuria (1) · Hyperlipidemias (1)
Male Urogenital Diseases (23) · Urogenital Diseases (23) · Genital Diseases (17) · Genital Diseases, Male (17) · Pathological Conditions, Signs and Symptoms (15) · Signs and Symptoms (14) · Prostatic Diseases (13) · Urological Manifestations (13) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Urologic Diseases (8) · Sexual Dysfunction, Physiological (5) · Urinary Bladder Diseases (5) · Lower Urinary Tract Symptoms (4) · Urethral Diseases (4)
Tamsulosin (3) · Transurethral Resection of Prostate (3) · alfuzosin (2) · Aquablation (1) · Ethanol (1) · Furosemide (1) · Interviews as Topic (1) · Lasers, Solid-State (1) · Lycopene (1) · Methoxyflurane (1) · Moxibustion (1) · Replantation (1) · Sodium Potassium Chloride Symporter Inhibitors (1) · Standard of Care (1) · Tadalafil (1)
Medi-Tate Ltd. (3) · Butterfly Medical Ltd. (2) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · Mansoura University (2) · Northwestern University (2) · University of North Carolina, Chapel Hill (2) · American Medical Systems (1) · Asan Medical Center (1) · Assiut University (1) · BE Technologies Inc (1) · Boston Scientific Corporation (1) · Brigham and Women's Hospital (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Chemical Resources (1) · Chinese University of Hong Kong (1)
United States (18) · Canada (4) · Egypt (4) · Germany (4) · Australia (3) · Israel (2) · Italy (2) · South Korea (2) · United Kingdom (2) · France (1) · Hong Kong (1) · India (1) · Lebanon (1) · New Zealand (1) · Portugal (1)
Ahmed Shokeir, PhD (1) · Alejandro Roldan-Alzate, PhD (1) · Allen D Seftel, MD (1) · Amy E Krambeck, MD (1) · Ari Isaacson, MD (1) · Bruce Choi (1) · Claus Roehrborn, M.D. (1) · David Levine, MD, MPH, MA (1) · Donald Neff (1) · Dr. Narsingh Verma, M.D. (1) · Emanuel Dias (1) · Francesco Porpiglia, MD (1) · Gordon Muir, MD (1)